Dosing Pump Market to Surpass USD 8.70 BN by 2030 on Account of Increasing Water and Wastewater Treatment Activities

Oct 16, 2023


As per SNS Insider’s research, the dosing pump market's future is bright, propelled by a confluence of factors including technological innovations, increased industrial activities, environmental consciousness, and expanding sectors.


Austin, Texas Oct 16, 2023 (Issuewire.com) - As per SNS Insider's research, the dosing pump market's future is bright, propelled by a confluence of factors including technological innovations, increased industrial activities, environmental consciousness, and expanding sectors.

The dosing pump market, as indicated in the SNS Insider report, reached a value of USD 5.3 billion in 2022 and is projected to increase to USD 8.70 billion by 2030, with a compound annual growth rate (CAGR) of 6.4% anticipated during the forecast period from 2023 to 2030.

Market Report Scope

A dosing pump is a mechanical device designed to deliver a precise quantity of a substance into a system. This substance can be anything from chemicals and disinfectants to water and even gases. Dosing pumps are engineered with meticulous precision, ensuring accurate and consistent dosing over a specified period. Dosing pumps are fundamental in water treatment plants, ensuring the right amount of chemicals is added to disinfect and purify water without compromising public health. Dosing pumps are employed in agricultural practices to administer fertilizers and pesticides accurately. This precision enhances crop yield while minimizing environmental impact.

Key Players included are:

  • SPX Flow Inc.
  • E.S. Ltd.
  • Seko SpA
  • Nikkiso Co. Ltd.
  • Grundfos Holding A/S
  • EMEC s.r.l.
  • Netzsch Pumpen Systeme GmbH
  • Idex Corporation
  • ProMinent GmbH
  • Blue-White Industries
  • Other key player

Get a Sample Report of the Dosing Pump Market @ https://www.snsinsider.com/sample-request/2824

Market Analysis

Innovation stands at the core of the dosing pump market's growth trajectory. Technological advancements have paved the way for the development of smart dosing pumps equipped with IoT capabilities and real-time monitoring features. These innovations enhance operational efficiency, reduce downtime, and minimize wastage, thereby driving the market forward.  The pressing need for sustainable water management solutions globally has led to a surge in water and wastewater treatment activities. Dosing pumps play a pivotal role in these processes by accurately administering chemicals for disinfection, pH adjustment, and coagulation. With stringent environmental regulations in place, industries are investing heavily in advanced dosing pump systems, propelling the market growth further. The chemical and petrochemical industries demand precise dosing solutions for the accurate blending of chemicals and additives. Dosing pumps ensure the exact proportioning of chemicals, enhancing the quality and efficiency of the production processes. With these industries experiencing significant growth, the demand for dosing pumps is set to escalate, contributing significantly to market expansion.

Market Segmentation and Sub-segmentation included are:

By Type:

  • Diaphragm Pumps
  • Solenoid Pumps
  • Piston Pumps
  • Plunger Pumps
  • Hydraulic Pumps
  • Peristaltic Pumps
  • Others

By Flow Rate:

  • Upto 50 L/min
  • 51-100 L/min
  • More than 100 L/min

By Application:

  • Water & Wastewater Treatment
  • Oil & Gas
  • Chemical processing
  • Pharmaceuticals
  • Food & Beverages
  • Paper & Pulp
  • Other Industries

Impact of Recession

The ongoing recession presents challenges for the dosing pump market, but it also brings forth opportunities for innovation and adaptation. By understanding the evolving market trends and implementing strategic approaches, businesses in the dosing pump industry can not only weather the storm but also emerge stronger and more resilient in the post-recession landscape. Innovation is the key to staying ahead in the market. Investing in research and development to create advanced, efficient, and environmentally friendly dosing pumps can attract discerning customers looking for cutting-edge solutions.

Impact of Russia-Ukraine War

The Russia-Ukraine war has undeniably reshaped the landscape of the dosing pump market. While challenges such as supply chain disruptions and price volatility persist, there are also opportunities arising from shifting demand dynamics and emerging markets. Adaptability, innovation, and strategic foresight will be pivotal for businesses in the dosing pump industry to navigate these turbulent times successfully. Automation and remote monitoring features are gaining traction, enabling businesses to optimize their processes and minimize operational disruptions caused by geopolitical uncertainties.

Do you have any queries related to Dosing Pump Market, Enquiry Now @ https://www.snsinsider.com/enquiry/2824

Key Regional Development

North America stands at the forefront of technological advancements in dosing pump technology. The region's robust industrial infrastructure and a strong focus on research and development have fostered innovations in dosing pump design and functionality. The increasing adoption of automated processes in industries such as water treatment, chemicals, and pharmaceuticals is a key driver in this region. Europe's dosing pump market is driven by a growing emphasis on sustainability and environmental consciousness. European nations are increasingly investing in eco-friendly solutions, pushing manufacturers to develop energy-efficient dosing pumps. The Asia-Pacific region is experiencing rapid industrialization and urbanization, leading to increased demand for dosing pumps across diverse sectors. Countries like China and India are witnessing substantial growth in water treatment, agriculture, and manufacturing industries, necessitating accurate dosing for various fluids and chemicals.

Key Takeaway from Dosing Pump Market Study

  • The diaphragm pump segment stands tall as a pivotal player in the market. These pumps are engineered to handle a wide range of chemicals, making them indispensable in industries such as petrochemicals, pharmaceuticals, and water treatment plants. Manufacturers have increasingly focused on energy-efficient diaphragm pump designs, aiding businesses in achieving sustainability goals and reducing operational costs.
  • The water and wastewater treatment segment is witnessing a paradigm shift toward smart dosing solutions. Integrating dosing pumps with advanced sensors and real-time monitoring systems is becoming standard practice. Additionally, the market is witnessing innovations in materials and designs, enhancing the pumps' resistance to corrosion and chemical wear.

Recent Developments Related to Dosing Pump Market

  • SEKO, a renowned global leader in chemical dosing pumps and metering solutions, has unveiled a significant upgrade to its WareDose warewash dosing pump systems. This innovative enhancement incorporates a state-of-the-art integrated Wi-Fi hub, empowering operators with continuous, real-time connectivity to their systems through their smartphones, 24/7.
  • The U.S. Food and Drug Administration (FDA) has recently given its clearance to Beta Bionics' automated insulin pump, marking a significant milestone in the management of type 1 diabetes. This innovative device, designed with cutting-edge technology, offers new hope and convenience to individuals living with this chronic condition.
  • Thermax Ltd., E.ON SE, General Electric Co., Valmet Oyj, Acciona SA, Vattenfall AB.

Table of Contents

  • Introduction
  • Research Methodology
  • Market Dynamics
  • Impact Analysis
    • COVID-19 Impact Analysis
    • Impact of Ukraine- Russia War
    • Impact of Ongoing Recession on Major Economies
  • Value Chain Analysis
  • Porter's 5 forces model
  • PEST Analysis
  • Dosing Pump Market Segmentation, By Type
  • Dosing Pump Market Segmentation, By Flow Rate
  • Dosing Pump Market Segmentation, By Application
  • Regional Analysis
  • Company Profile
  • Competitive Landscape
  • USE Cases and Best Practices
  • Conclusion

Buy a Single-User PDF of the Dosing Pump Market Report @ https://www.snsinsider.com/checkout/2824

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand - Head of Business Development & Strategy

[email protected]

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Website: https://www.snsinsider.com

Media Contact

SNS Insider Pvt Ltd


[email protected]

+1-415-230-0044

http://www.snsinsider.com

Source :SNS Insider

This article was originally published by IssueWire. Read the original article here.

More News
The 2026 election could reshape healthcare
Oct 22, 2026

The 2026 election could reshape healthcare

New Yorkers march in support of universal healthcare this summer. | LightRocket via Getty Images Americans are furious about the state of our healthcare system.  A recent KFF poll found 60 percent of US adults worry about the cost of medical care — more than gasoline, food and groceries, or their rent or mortgage. One in three Americans say they worry every day or almost every day about their ability to afford healthcare, per a new survey from the Pew Research Center. There seems to be a growing appetite for reform, too: More than 65 percent of Americans say they support the government spending more tax dollars to lower healthcare costs.  Democrats are trying to weaponize those frustrations against the Republicans who currently hold Congress and the White House. By a 2-to-1 margin, voters say they trust Democrats over Republicans on healthcare. That could mean single-payer Medicare-for-all or a new public insurance option or maybe something else. What all this energy leads to will depend on what happens in November. The candidates themselves are framing the stakes in those existential terms.  Sign up for the Good Medicine newsletter Our political wellness landscape has shifted: new leaders, shady science, contradictory advice, broken trust, and overwhelming systems. How is anyone supposed to make sense of it all? Vox’s senior correspondent Dylan Scott has been on the health beat for a long time, and every week, he’ll wade into sticky debates, answer fair questions, and contextualize what’s happening in American health care policy. Sign up here. “Medicare for all is where we need to go,” Abdul El-Sayed, the Democratic candidate in the Michigan Senate race whose support for the policy has been widely covered, said during an August interview with CNN. “And my hope is, both coming out of the 2026 midterms and then out of 2028, that we’re going to be on our way to a Senate majority to be able to get this done.” Real change will have to wait for the 2028 presidential election and a new occupant in the White House. But this year’s midterms are still a make-or-break moment: The candidates who get elected this year, and how they shape the upcoming presidential primary debate and actions in Congress, will determine whether healthcare reform happens at all.  If you’re fed up with the state of American healthcare, and you want to see a change, you should show up for the midterms on Tuesday, November 3. Big midterm wins can beget big healthcare wins  The classic pattern in American elections is that more voters go to the polls during presidential campaigns than during the midterm elections when only House and Senate seats are on the ballot. Turnout has started to tick up for the midterms in recent years, but it still trails behind presidential years. Midterms suffer from the perception that there’s not as much at stake if the White House is not on the line. But that’s never been strictly true.  Midterm elections are extraordinarily important in shaping the future of policymaking, even if the payoff is delayed. They help determine both the character of the Congress that could eventually pass a major bill after the next presidential election, and the kind of ideas and policies that are going to be prioritized. “Voters should see 2026 and 2028 as the elections that will guide the next big change in our healthcare system,” said Natalie Davis, CEO and co-founder of the advocacy group United States of Care, in a statement to Vox. “These elections will be how voters’ demands are heard — and will tell us whether the next real window for change will come with serious reforms or missed opportunity.” A walk through the recent history of healthcare reform should help make the stakes of the 2026 elections clear. In 2006, the national mood looked similar to what we’re seeing today. A very unpopular Republican president was in office, and the country had soured on his agenda. George W. Bush’s foreign wars and his misguided attempt to overhaul Social Security gave Democrats an opportunity to win big in the 2006 midterms — and they did. Dems won more than 30 seats and secured a comfortable majority in the House. In the Senate, they won six seats and narrowly took control of that chamber too. It was a resounding rejection of the Bush administration, and it set up the next decade of Democratic policymaking. At the highest level, the midterms gave energy to the progressive wing of the Democratic Party, united as they were around their opposition to the Iraq War, and that energy carried over to the presidential primary. Barack Obama defeated Hillary Clinton and won the presidency, springboarding off of the excitement that started with the 2006 elections. Dems’ success in the midterms also helped put lowering healthcare costs at the forefront of the Democratic agenda. That encouraged both Obama and Clinton to develop detailed healthcare policy proposals during their primary campaigns and ultimately set the stage for the Democrats to pursue the Affordable Care Act once they had full control of the government in 2009. And then there is the literal size of the congressional majorities that parties need to pass their agenda. Voters may not spend much time thinking about whip counts, but one or two elections in a midterm year can ultimately decide the fate of the next president’s agenda.  Part of the reason Democrats were able to pass the ACA was that they built on their huge wins in 2006 with more wins in 2008 and held massive congressional majorities once Obama was sworn in. And once the debate over healthcare reform really got started, they needed every single vote. It was especially important in the Senate: Democrats had exactly 60 votes in 2009. That meant if all of them united together, they could pass filibuster-proof legislation — so long as nobody defected. That was only possible because in 2006 Mark Pryor won a Senate seat in Arkansas, Sherrod Brown triumphed in a Senate race in Ohio, and Jon Tester beat an incumbent Republican in Montana.  Without those wins in 2006, the Democratic legislative agenda in 2009 would probably have looked different. They might’ve had to pursue a more limited healthcare reform plan; maybe the ACA wouldn’t have passed at all. What kind of Democrats will be on the rise in 2028? The 2006 midterms both created the opportunity for the ACA — and set the limits on what the legislation could actually achieve. Democrats had that 60-seat Senate majority, but within it were many more moderate members. Policies like the public option (which would have authorized the government to create its own health insurance plan to sell alongside private insurance) couldn’t get sufficient support. That is the dilemma of policymaking: You need those swing-seat members to win, which often means tacking to the center, but you also can’t pass anything they won’t get on board with.  Nevertheless, that is a good kind of political problem to have, one which Democrats would be thrilled to face in January 2029. All of which brings us to 2026. What are we going to do now? It all starts with the vote count. Most projections expect the Democrats to win between 10 and 20 House seats. But the difference between 10 and 20 could be substantial. The cushier the majority, the further you can push the policy agenda. More than 30 House Democrats actually voted against the ACA, but they could still narrowly pass the bill because of the huge majority that they had started building in 2006.  If you live in one of the districts — like Arizona’s Sixth or Colorado’s Eighth or Florida’s 22nd, to name just a couple of the 21 toss-up races identified by the Cook Political Report this year — that forecasters say is competitive this year, you could have an outsized say in what the future of policymaking looks like. But even in safe districts, you should vote: Elections are the most reliable way we have to gauge public opinion, and strong victories for the candidates who prioritize healthcare send a message. The same goes for the Senate. If Democrats sweep all of the competitive races, they could have up to 55 seats in the Senate in 2027 — with a chance to build on it in 2028. If you are a voter in Kansas, Michigan, Ohio, Texas, Alaska, Maine, New Hampshire, or Iowa, your ballot carries extra weight for the next steps in US healthcare reform. If the Democrats can reach 60 votes again in 2029, they would have much more flexibility about what to pass. Even if they fall short of that magic number, the more of a cushion they have above 50, the more likely that their Senate leaders can find support for altering Senate rules for the filibuster and get an ambitious bill approved. How you can get involved this election If there is ever going to be a path to a true healthcare overhaul, it starts with this year’s elections. If you want to see a change, you can vote — and you can do more than that.  Talk to your neighbors. Phone bank for candidates you believe in.  You can even sign up to drive people to the polls on Election Day. The results of this year’s midterms will also set the terms of the debate among Democrats. We are likely to see “show” bills advanced by Dems next year that may have no chance of being signed by President Donald Trump, but that will give us a sense of what kind of policies the party wants to pursue and how much support there is for them. Believe it or not, the first Medicare prescription drug negotiations bill passed the House in 2007 after Democrats’ big wins in 2006 — even though the policy didn’t become law for another 15 years. The broader public may not pay much attention to this kind of doomed-to-fail legislation, but it is often a window into the future. “One challenge for Democrats is finding the next big health care idea beyond the Affordable Care Act that will resonate with voters and respond to their affordability concerns,” said Larry Levitt, executive vice president for health policy at KFF. “One big difference between now and 2006 i

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Copyright © 2015 - 2026 Daily Transport. All Rights Reserved.

About Us

Thailand Tribunal is the country’s next generation of digital news portal, bringing you non-stop news on the happenings in the country and all over the world.

Subscribe Now!